Bronchiolitis Obliterans Syndrome Clinical Trial
— OSCILLOPOUMONA study to evaluate the role of forced oscillation in precocious diagnosis of bronchiolitis obliterans syndrome in patients with pulmonary transplant (time difference in detecting distal airways functional impairment by forced oscillation and the standard technique using spirometry).
Status | Completed |
Enrollment | 110 |
Est. completion date | September 2015 |
Est. primary completion date | September 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patients of more than 18 year-old. - Patients with cardiopulmonary transplant or bilateral lung transplant. - Clinically stable patients Exclusion Criteria: - Patients already diagnosed with bronchiolitis obliterans. - Respiratory infection. - Acute graft rejection. - Mechanical complications (bronchial dehiscence, pneumothorax, pleural effusion). - Iatrogenic pneumopathy. - Inability to perform Respiratory function test. |
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Country | Name | City | State |
---|---|---|---|
France | Hôpital FOCH | Suresnes | Ile de France |
Lead Sponsor | Collaborator |
---|---|
Hopital Foch |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Time difference in diagnosing distal airways functional disturbance by forced oscillation and by spirometry (standard methode). | 2 years | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01009619 -
Azithromycin in Bronchiolitis Obliterans Syndrome
|
Phase 4 | |
Recruiting |
NCT04391335 -
Novel Pulmonary Function Measures for Diagnosis of Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem-Cell Transplantation in Children
|
||
Recruiting |
NCT05922761 -
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
|
Phase 2 | |
Recruiting |
NCT05250037 -
The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study)
|
||
Enrolling by invitation |
NCT04039347 -
Extension Trial on Efficacy / Safety of L-CsA + SoC in Treating BOS in Post Single or Double Lung Transplant (BOSTON-3)
|
Phase 3 | |
Recruiting |
NCT05413356 -
Ruxolitinib for Newly Diagnosed Bronchiolitis Obliterans Syndrome
|
Phase 2 | |
Recruiting |
NCT00774449 -
Characterization of Bronchiolitis-obliterans Syndrome (BOS) Following Lung Transplantation
|
N/A | |
Terminated |
NCT03978637 -
Safety and Efficacy of Itacitinib in Participants With Bronchiolitis Obliterans Syndrome Following Lung Transplantation
|
Phase 1/Phase 2 | |
Completed |
NCT02316392 -
Imaging and Understanding BOS in Lung Transplantation
|
||
Completed |
NCT00528853 -
Correlation of Lung Biopsy, BAL, and High Resolution CT Scan in Lung Transplantation
|
N/A | |
Recruiting |
NCT06018766 -
LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.
|
Phase 2 | |
Recruiting |
NCT02669251 -
Alvelestat (MPH966), an Oral Neutrophil Elastase Inhibitor, in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation
|
Phase 1/Phase 2 | |
Completed |
NCT02863835 -
Evaluation of Electrical Impedance Tomography for the Diagnosis of Chronic Rejection in Lung Transplants Recipients
|
N/A | |
Recruiting |
NCT03072849 -
Early Detection and Management of Bronchiolitis Obliterans Syndrome Following Pediatric Hematopoietic Stem Cell Transplantation
|
N/A |